To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...

With increasing demand and higher costs, ensuring appropriate patient access is more critical than ever and 2025 will likely ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...

Blockbuster GLP-1 medications are changing patient care, impacting surgery volumes and reshaping the financial landscape of the healthcare industry.

While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that ...

There are additional considerations that physicians need to consider when prescribing GLP-1s to patients with disabilities or ...

the drugs may have other uses. For example, a recent study showed that GLP-1s may help curb binge drinking. In a review conducted by scientists from the United Kingdom and Canada, researchers examined ...

The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.

Results presented here showed patients who had significant weight loss prior to total hip arthroplasty with use of a GLP-1 receptor agonist experienced a decreased risk for complications but an ...

As it gets harder to offer compounded GLP-1s, many telehealth companies are pivoting to hormone replacement therapy.